Filing Details
- Accession Number:
- 0001209191-13-027212
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-05-17 16:13:16
- Reporting Period:
- 2013-05-15
- Filing Date:
- 2013-05-17
- Accepted Time:
- 2013-05-17 16:13:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1197032 | F Ian Smith | C/O Vertex Pharmaceuticals Incorporated 130 Waverly St. Cambridge MA 02139 | Evp & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2013-05-15 | 509 | $79.51 | 24,268 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-05-15 | 100 | $80.50 | 24,168 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 5,306 | Indirect | 401(k) |
Footnotes
- Transaction made pursuant to Mr. Smith's company approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $79.51 (range $79.38 to $79.75).
- Mr. Smith undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
